181 related articles for article (PubMed ID: 23998921)
1. Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.
Leung CY; Park J; De Schutter JW; Sebag M; Berghuis AM; Tsantrizos YS
J Med Chem; 2013 Oct; 56(20):7939-50. PubMed ID: 23998921
[TBL] [Abstract][Full Text] [Related]
2. Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenyls.
De Schutter JW; Shaw J; Lin YS; Tsantrizos YS
Bioorg Med Chem; 2012 Sep; 20(18):5583-91. PubMed ID: 22884353
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells.
Lin YS; Park J; De Schutter JW; Huang XF; Berghuis AM; Sebag M; Tsantrizos YS
J Med Chem; 2012 Apr; 55(7):3201-15. PubMed ID: 22390415
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.
Park J; Leung CY; Matralis AN; Lacbay CM; Tsakos M; Fernandez De Troconiz G; Berghuis AM; Tsantrizos YS
J Med Chem; 2017 Mar; 60(5):2119-2134. PubMed ID: 28208018
[TBL] [Abstract][Full Text] [Related]
5. Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
De Schutter JW; Park J; Leung CY; Gormley P; Lin YS; Hu Z; Berghuis AM; Poirier J; Tsantrizos YS
J Med Chem; 2014 Jul; 57(13):5764-76. PubMed ID: 24911527
[TBL] [Abstract][Full Text] [Related]
6. Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure.
Park J; Lin YS; De Schutter JW; Tsantrizos YS; Berghuis AM
BMC Struct Biol; 2012 Dec; 12():32. PubMed ID: 23234314
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.
Fernández D; Ortega-Castro J; Mariño L; Perelló J; Frau J
J Comput Aided Mol Des; 2015 Jul; 29(7):667-80. PubMed ID: 26081258
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
9. Structure of human farnesyl pyrophosphate synthase in complex with an aminopyridine bisphosphonate and two molecules of inorganic phosphate.
Park J; Lin YS; Tsantrizos YS; Berghuis AM
Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):299-304. PubMed ID: 24598914
[TBL] [Abstract][Full Text] [Related]
10. Discovery of thienopyrimidine-based inhibitors of the human farnesyl pyrophosphate synthase--parallel synthesis of analogs via a trimethylsilyl ylidene intermediate.
Leung CY; Langille AM; Mancuso J; Tsantrizos YS
Bioorg Med Chem; 2013 Apr; 21(8):2229-2240. PubMed ID: 23477945
[TBL] [Abstract][Full Text] [Related]
11. Crystallographic and thermodynamic characterization of phenylaminopyridine bisphosphonates binding to human farnesyl pyrophosphate synthase.
Park J; Rodionov D; De Schutter JW; Lin YS; Tsantrizos YS; Berghuis AM
PLoS One; 2017; 12(10):e0186447. PubMed ID: 29036218
[TBL] [Abstract][Full Text] [Related]
12. Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase.
Gritzalis D; Park J; Chiu W; Cho H; Lin YS; De Schutter JW; Lacbay CM; Zielinski M; Berghuis AM; Tsantrizos YS
Bioorg Med Chem Lett; 2015 Mar; 25(5):1117-23. PubMed ID: 25630225
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
[TBL] [Abstract][Full Text] [Related]
14. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
Wiemer AJ; Tong H; Swanson KM; Hohl RJ
Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
Kavanagh KL; Guo K; Dunford JE; Wu X; Knapp S; Ebetino FH; Rogers MJ; Russell RG; Oppermann U
Proc Natl Acad Sci U S A; 2006 May; 103(20):7829-34. PubMed ID: 16684881
[TBL] [Abstract][Full Text] [Related]
16. Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis.
Savino S; Toscano A; Purgatorio R; Profilo E; Laghezza A; Tortorella P; Angelelli M; Cellamare S; Scala R; Tricarico D; Marobbio CMT; Perna F; Vitale P; Agamennone M; Dimiccoli V; Tolomeo A; Scilimati A
Eur J Med Chem; 2018 Oct; 158():184-200. PubMed ID: 30216851
[TBL] [Abstract][Full Text] [Related]
17. Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase.
De Schutter JW; Zaretsky S; Welbourn S; Pause A; Tsantrizos YS
Bioorg Med Chem Lett; 2010 Oct; 20(19):5781-6. PubMed ID: 20801032
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition.
Dunford JE
Curr Pharm Des; 2010; 16(27):2961-9. PubMed ID: 20722615
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
Dunford JE; Kwaasi AA; Rogers MJ; Barnett BL; Ebetino FH; Russell RG; Oppermann U; Kavanagh KL
J Med Chem; 2008 Apr; 51(7):2187-95. PubMed ID: 18327899
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in understanding the mechanism of action of bisphosphonates.
Coxon FP; Thompson K; Rogers MJ
Curr Opin Pharmacol; 2006 Jun; 6(3):307-12. PubMed ID: 16650801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
